Optimization and Validation of FePro Cell Labeling Method

被引:51
作者
Janic, Branislava
Rad, Ali M.
Jordan, Elaine K.
Iskander, A. S. M.
Ali, Md M.
Varma, N. Ravi S.
Frank, Joseph A.
Arbab, Ali S.
机构
[1] Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Hospital, Detroit, MI
[2] Frank Laboratory, Radiology and Imaging Sciences Clinical Center, The National Institutes of Health, Bethesda, MD
[3] Intramural Research Program, National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD
来源
PLOS ONE | 2009年 / 4卷 / 06期
关键词
D O I
10.1371/journal.pone.0005873
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Current method to magnetically label cells using ferumoxides (Fe)-protamine (Pro) sulfate (FePro) is based on generating FePro complexes in a serum free media that are then incubated overnight with cells for the efficient labeling. However, this labeling technique requires long (>12-16 hours) incubation time and uses relatively high dose of Pro (5-6 mu g/ml) that makes large extracellular FePro complexes. These complexes can be difficult to clean with simple cell washes and may create low signal intensity on T2* weighted MRI that is not desirable. The purpose of this study was to revise the current labeling method by using low dose of Pro and adding Fe and Pro directly to the cells before generating any FePro complexes. Human tumor glioma (U251) and human monocytic leukemia cell (THP-1) lines were used as model systems for attached and suspension cell types, respectively and dose dependent (Fe 25 to 100 mu g/ml and Pro 0.75 to 3 mu g/ml) and time dependent (2 to 48 h) labeling experiments were performed. Labeling efficiency and cell viability of these cells were assessed. Prussian blue staining revealed that more than 95% of cells were labeled. Intracellular iron concentration in U251 cells reached similar to 30-35 pg-iron/cell at 24 h when labeled with 100 mu g/ml of Fe and 3 mu g/ml of Pro. However, comparable labeling was observed after 4 h across the described FePro concentrations. Similarly, THP-1 cells achieved similar to 10 pg-iron/cell at 48 h when labeled with 100 mu g/ml of Fe and 3 mu g/ml of Pro. Again, comparable labeling was observed after 4 h for the described FePro concentrations. FePro labeling did not significantly affect cell viability. There was almost no extracellular FePro complexes observed after simple cell washes. To validate and to determine the effectiveness of the revised technique, human T-cells, human hematopoietic stem cells (hHSC), human bone marrow stromal cells (hMSC) and mouse neuronal stem cells (mNSC C17.2) were labeled. Labeling for 4 hours using 100 mu g/ml of Fe and 3 mu g/ml of Pro resulted in very efficient labeling of these cells, without impairing their viability and functional capability. The new technique with short incubation time using 100 mu g/ml of Fe and 3 mu g/ml of Pro is effective in labeling cells for cellular MRI.
引用
收藏
页数:8
相关论文
共 18 条
[1]  
Abou-Montet K, 2005, MOL IMAGING, V4, P165
[2]   Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging [J].
Ahrens, ET ;
Feili-Hariri, M ;
Xu, H ;
Genove, G ;
Morel, PA .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (06) :1006-1013
[3]   Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings [J].
Arbab, Ali S. ;
Janic, Branislava ;
Knight, Robert A. ;
Anderson, Stasia A. ;
Pawelczyk, Edyta ;
Rad, Ali M. ;
Read, Elizabeth J. ;
Pandit, Sunil D. ;
Frank, Joseph A. .
FASEB JOURNAL, 2008, 22 (09) :3234-3246
[4]   Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells [J].
Arbab, AS ;
Yocum, GT ;
Rad, AM ;
Khakoo, AY ;
Fellowes, V ;
Read, EJ ;
Frank, JA .
NMR IN BIOMEDICINE, 2005, 18 (08) :553-559
[5]   A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging [J].
Arbab, AS ;
Wilson, LB ;
Ashari, P ;
Jordan, EK ;
Lewis, BK ;
Frank, JA .
NMR IN BIOMEDICINE, 2005, 18 (06) :383-389
[6]   Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI [J].
Arbab, AS ;
Yocum, GT ;
Kalish, H ;
Jordan, EK ;
Anderson, SA ;
Khakoo, AY ;
Read, EJ ;
Frank, JA .
BLOOD, 2004, 104 (04) :1217-1223
[7]   Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles [J].
Dodd, CH ;
Hsu, HC ;
Chu, WJ ;
Yang, PG ;
Zhang, HG ;
Mountz, JD ;
Zinn, K ;
Forder, J ;
Josephson, L ;
Weissleder, R ;
Mountz, JM ;
Mountz, JD .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 256 (1-2) :89-105
[8]   IRON-OXIDE ENHANCED MR-IMAGING OF THE LIVER AND SPLEEN - REVIEW OF THE 1ST-5 YEARS [J].
FERRUCCI, JT ;
STARK, DD .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (05) :943-950
[9]   Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells [J].
Lewin, M ;
Carlesso, N ;
Tung, CH ;
Tang, XW ;
Cory, D ;
Scadden, DT ;
Weissleder, R .
NATURE BIOTECHNOLOGY, 2000, 18 (04) :410-414
[10]   Cell tagging with clinically approved iron oxides: Feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency [J].
Matuszewski, L ;
Persigehl, T ;
Wall, A ;
Schwindt, W ;
Tombach, B ;
Fobker, M ;
Poremba, C ;
Ebert, W ;
Heindel, W ;
Bremer, C .
RADIOLOGY, 2005, 235 (01) :155-161